A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Titel:
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Auteur:
Sandhu, Shahneen K. Papadopoulos, Kyri Fong, Peter C. Patnaik, Amita Messiou, Christina Olmos, David Wang, George Tromp, Brenda J. Puchalski, Thomas A. Balkwill, Frances Berns, Birge Seetharam, Shobha Bono, Johann S. de Tolcher, Anthony W.